| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -28,292,520 |
| Depreciation and amortization | 1,355,538 |
| Loss/(gain) on disposal of property and equipment | -17,552 |
| Noncash lease expense | 941,015 |
| Bad debt recovery | -9,784 |
| Loss on write-off of related party receivables | 216,399 |
| Contract modification - related party | -280,545 |
| Share-based compensation | 14,236 |
| Interest expense paid in equity shares | 294,977 |
| Accrued interest on notes payable | 1,050,296 |
| Non-cash royalty income | 99,001 |
| Amortization of original issue discounts on notes payable | 41,667 |
| Loan origination costs | 5,000 |
| Receipt of sol from staking | 12,522 |
| Non-cash transaction fees | 2,755 |
| Unrealized gain on digital assets | 150,009 |
| Loss on excess fair value of warrants | -15,088,812 |
| Changes in fair value of warrant liability | 10,933,412 |
| Trade receivables | 1,970,245 |
| Trade receivables - related party | -108,488 |
| Inventory | -403,585 |
| Contract assets | -11,324 |
| Prepaid expenses and other current assets | 99,745 |
| Other assets | -219,510 |
| Accounts payable | -27,314 |
| Sales tax payable | 2,984 |
| Operating lease liabilities | -932,019 |
| Deposits from customers | -250,071 |
| Accrued expenses | 841,348 |
| Contract liabilities | 400,851 |
| Deferred revenue | -89,621 |
| Income taxes payable | -152,654 |
| Other liabilities | 14,526 |
| Net cash provided by/(used in) operating activities | 159,315 |
| Purchase of property and equipment | 1,931,534 |
| Proceeds from sale of property and equipment | 29,257 |
| Royalties on related party revenues | 40,000 |
| Purchase of digital assets | 998,462 |
| Investment in masterpiecevr | 100,000 |
| Net cash used by investing activities | -2,960,739 |
| Proceeds on revolving line of credit | 33,144,497 |
| Payments on revolving line of credit | 33,093,412 |
| Payments on debt | 1,095,564 |
| Payments on paycheck protection program loans | -50,628 |
| Proceeds on loan from ceo | 200,000 |
| Payments on loan from ceo | 200,000 |
| Proceeds from notes payable | 500,000 |
| Proceeds from warrant exercises | 3,438,918 |
| Proceeds from offerings | 1,463,550 |
| Expenses on offerings | 232,100 |
| Net cash provided by financing activities | 4,075,261 |
| Effect of currency translation | -347,188 |
| Net increase/(decrease) in cash, cash equivalents, and restricted cash | 926,649 |
| Cash and cash equivalents at beginning of period | 5,420,392 |
| Cash and cash equivalents at end of period | 6,347,041 |
CEMTREX INC (CETXP)
CEMTREX INC (CETXP)